HONG WEN,INDRAJIT GHOSH,SHOUFENG LI,SUDHA VIPPAGUNTA,WEI-QIN TONG
申请号：
BRPI1009468
公开号：
BRPI1009468A2
申请日:
2010.03.18
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The invention provides a pharmaceutical oral fixed dose combination of aliskiren and valsartan. Aliskiren is shown to slow the dissolution rate of valsartan and the resultant undesirable gelling of valsartan in the presence of aliskiren is overcome by the use of disintegrants.
